The pitch vs. the price tag
Walk through any supplement aisle and the krill oil bottle is the one with the red liquid, the prominent phospholipid-bound omega-3 claim, and a price tag two to five times higher than the fish oil next to it. The marketing argument: krill delivers EPA and DHA attached to phospholipids rather than triglycerides, which supposedly means dramatically better absorption — so you need less, and the price evens out. What changed recently is the evidence: two large network meta-analyses published in 2024 finally pooled enough randomized trials to compare the two head-to-head — and the results are not what either side tends to claim.
Take the free supplement quiz →
---
Same omega-3s, different packaging
Both supplements deliver the same two active molecules — eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) — which your body uses to build resolvins and other anti-inflammatory signaling lipids. The difference is the carrier. Fish oil binds them to triglycerides (TG, re-esterified TG, or ethyl ester); krill oil binds them to phospholipids, mainly phosphatidylcholine, plus a small amount of natural astaxanthin. Phospholipids do not require bile acid emulsification to absorb — the mechanistic basis for the better-absorbed claim. Whether it matters at real-world doses is the question.
Does krill oil really absorb better?
Evidence: Moderate. The cleanest answer comes from the 2024 network meta-analysis in Heliyon, which pooled 60 randomized controlled trials. At low to moderate doses — under 2,000 mg of oil — krill oil's phospholipid form produced the highest area under the curve of any formulation tested. But the picture flipped at higher doses: for raising the omega-3 index, the long-term blood marker that actually correlates with cardiovascular risk, fish oil above 3,000 mg in re-esterified triglyceride or ethyl ester form was as effective or more effective than any krill oil dose studied. A widely cited 2011 head-to-head trial found that when EPA+DHA doses were matched, krill and fish oil produced essentially identical incorporation into plasma phospholipids over 4 weeks. The phospholipid advantage is real but small: at 250–500 mg of EPA+DHA it probably helps, while at 1,500–3,000 mg — the range that actually moves cardiovascular and inflammatory endpoints — fish oil delivers the same blood levels at roughly one-fifth the cost.
Triglycerides, heart outcomes, and inflammation
Evidence: Strong for lipids, with no clear winner. The 2020 lipid-modifying network meta-analysis of 64 RCTs found krill and fish oil produce comparable reductions in triglycerides, LDL-C, and total cholesterol. The 2024 cardiovascular network meta-analysis agreed: krill oil at 2,000–2,900 mg per day cut triglycerides, fish oil ethyl esters above 3,000 mg cut total cholesterol — both worked, neither dominated. A 2021 JAMA Network Open trial of a high-dose krill agent in severe hypertriglyceridemia worked too — at 4 g per day, a dose that erases krill's cost case entirely. The clinically meaningful dose is 2–4 grams of EPA+DHA per day: roughly $15–25 a month as a fish oil concentrate, or $60–120 as krill. On hard cardiovascular endpoints, honesty matters: REDUCE-IT, STRENGTH, VITAL, and ASCEND were almost entirely fish-oil-derived trials. There is no multi-thousand-person krill oil equivalent — anyone claiming krill is proven to reduce heart attacks is extrapolating beyond the data. For inflammation, a 2025 comparative analysis found krill's phospholipid-plus-astaxanthin combination showed stronger antioxidant effects in cell and animal models; whether that translates to humans at real doses is unsettled.
The astaxanthin catch
Krill oil's natural astaxanthin helps it resist oxidation, and the marketing leans on it heavily. But typical krill supplements provide 100–500 mcg per serving, while the trials showing astaxanthin benefits — skin elasticity, oxidative stress, exercise recovery — use 6–12 mg per day. You would need 12–60 capsules to get there. If astaxanthin is what you want, buy it standalone and pair it with fish oil.
---
At a glance
| Feature | Fish oil | Krill oil |
|---|---|---|
| Source | Anchovy, sardine, mackerel, salmon | Antarctic krill |
| EPA+DHA carrier | Triglyceride, rTG, or ethyl ester | Phospholipid |
| EPA+DHA per 1,000 mg oil | ~300–600+ mg | ~120–250 mg |
| Astaxanthin | None unless added | ~100–500 mcg |
| Cost per gram EPA+DHA | $0.05–$0.15 | $0.30–$0.80 |
---
How to actually choose
- Choose fish oil if you want cost-effective dosing at 1,500 mg EPA+DHA or higher, you are targeting triglycerides, cardiovascular risk, or inflammation, and you want the form the large trials validated — pick an IFOS or USP certified concentrate. The IFOS program tests for oxidation, heavy metals, and PCBs, making a five-star fish oil essentially indistinguishable from krill in purity.
- Choose krill oil if fish oil gives you persistent fishy reflux, you take a low dose (under 500 mg EPA+DHA) where the phospholipid edge shows up, or cost is not a factor. Krill is also naturally very low in mercury and PCBs.
- Dose by goal: 1,000–2,000 mg EPA+DHA daily for general health, 2,000–4,000 mg for triglycerides, 200–300 mg DHA in pregnancy, 1,000–2,000 mg EPA-dominant for mood support. Take with your largest meal — both absorb dramatically better with dietary fat — and refrigerate after opening.
For most people, the math heavily favors a high-quality fish oil concentrate: at equivalent EPA+DHA doses the effects are essentially the same, and krill costs 3–5x more per gram.
Caution: omega-3 supplements can interact with anticoagulants, including warfarin and direct oral anticoagulants, and may affect bleeding risk before surgery. Consult your physician first if you take blood thinners, have a bleeding disorder, or have a fish or shellfish allergy.